Healthcare Infection Control Practices Advisory Committee, (HICPAC), 29772 [2010-12749]

Download as PDF wwoods2 on DSK1DXX6B1PROD with NOTICES 29772 Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices Contact Person: Carol Hamelink, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4192, MSC 7850, Bethesda, MD 20892, (301) 213– 9887, hamelinc@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Health and Related Behaviors of Individuals and Populations. Date: June 23, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, VA 22314. Contact Person: Karin F. Helmers, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3166, MSC 7770, Bethesda, MD 20892, 301–254– 9975, helmersk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Non-HIV Anti-Infective Therapeutics. Date: June 23–24, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications, Place: George Washington University Inn, 824 New Hampshire Avenue, NW., Washington, DC 20037. Contact Person: Rossana Berti, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3191, MSC 7846, Bethesda, MD 20892, 301–402– 6411, bertiros@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Sensory, Motor, and Cognitive Neuroscience. Date: June 23, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: One Washington Circle Hotel, One Washington Circle, NW., Washington, DC 20037. Contact Person: John Bishop, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408– 9664, bishopj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; ARRA: Chronic Fatigue Syndrome, Fibromyalgia Syndrome, and Temporomandibular Disorder Competitive Revisions. Date: June 23, 2010. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate grant applications, Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Lynn E Luethke, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5166, MSC 7844, Bethesda, MD 20892, (301) 806– 3323, luethkel@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member VerDate Mar<15>2010 15:26 May 26, 2010 Jkt 220001 Conflicts: Lung Host Defense and Cystic Fibrosis Applications. Date: June 23, 2010. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Everett E Sinnett, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2178, MSC 7818, Bethesda, MD 20892, 301–435– 1016, sinnett@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Risk Prevention and Health Behavior. Date: June 23–25, 2010. Time: 7 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202. Contact Person: Claire E. Gutkin, PhD, MPH, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3138, MSC 7759, Bethesda, MD 20892, 301–594– 3139, gutkincl@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: May 21, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–12788 Filed 5–26–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee, (HICPAC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: Times and Dates: 9 a.m.–5 p.m., June 17, 2010; 9 a.m.–12 p.m., June 18, 2010. Place: CDC, Global Communications Center, Building 19, Auditorium B3, 1600 Clifton Road, NE., Atlanta, Georgia 30333. Status: This meeting is open to the public, limited only by the space available. Please register for the meeting online at https://www.cdc.gov/hicpac or by sending an e-mail to hicpac@cdc.gov. Purpose: The Committee is charged with providing advice and guidance to PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 the Secretary, the Assistant Secretary for Health, the Director, CDC, and the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) regarding (1) The practice of healthcare infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters to be Discussed: The agenda will include: Updates on CDC’s activities for healthcare associated infections; the draft guideline for the Prevention of Norovirus Gastroenteritis Outbreaks in Healthcare Settings; the draft guideline for prevention of infections among patients in neonatal intensive care units (NICU); the draft guideline for Infection Control in Healthcare Personnel; and a discussion of infection control in ambulatory care settings. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Michelle King, HICPAC, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC, 1600 Clifton Road, N.E., Mailstop A–07, Atlanta, Georgia 30333 Telephone (404) 639– 2936. E-mail: hicpac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 19, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–12749 Filed 5–26–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meeting In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and E:\FR\FM\27MYN1.SGM 27MYN1

Agencies

[Federal Register Volume 75, Number 102 (Thursday, May 27, 2010)]
[Notices]
[Page 29772]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-12749]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee, 
(HICPAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
committee:
    Times and Dates: 9 a.m.-5 p.m., June 17, 2010; 9 a.m.-12 p.m., June 
18, 2010.
    Place: CDC, Global Communications Center, Building 19, Auditorium 
B3, 1600 Clifton Road, NE., Atlanta, Georgia 30333.
    Status: This meeting is open to the public, limited only by the 
space available. Please register for the meeting online at https://www.cdc.gov/hicpac or by sending an e-mail to hicpac@cdc.gov.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, the Assistant Secretary for Health, the 
Director, CDC, and the Director, National Center for Emerging and 
Zoonotic Infectious Diseases (NCEZID) regarding (1) The practice of 
healthcare infection control; (2) strategies for surveillance, 
prevention, and control of infections (e.g., nosocomial infections), 
antimicrobial resistance, and related events in settings where 
healthcare is provided; and (3) periodic updating of guidelines and 
other policy statements regarding prevention of healthcare-associated 
infections and healthcare-related conditions.
    Matters to be Discussed: The agenda will include: Updates on CDC's 
activities for healthcare associated infections; the draft guideline 
for the Prevention of Norovirus Gastroenteritis Outbreaks in Healthcare 
Settings; the draft guideline for prevention of infections among 
patients in neonatal intensive care units (NICU); the draft guideline 
for Infection Control in Healthcare Personnel; and a discussion of 
infection control in ambulatory care settings.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Michelle King, HICPAC, 
Division of Healthcare Quality Promotion, National Center for Emerging 
and Zoonotic Infectious Diseases, CDC, 1600 Clifton Road, N.E., 
Mailstop A-07, Atlanta, Georgia 30333 Telephone (404) 639-2936. E-mail: 
hicpac@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: May 19, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-12749 Filed 5-26-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.